These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28916737)

  • 1. Determining Ribavirin's mechanism of action against Lassa virus infection.
    Carrillo-Bustamante P; Nguyen THT; Oestereich L; Günther S; Guedj J; Graw F
    Sci Rep; 2017 Sep; 7(1):11693. PubMed ID: 28916737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset.
    Safronetz D; Rosenke K; Westover JB; Martellaro C; Okumura A; Furuta Y; Geisbert J; Saturday G; Komeno T; Geisbert TW; Feldmann H; Gowen BB
    Sci Rep; 2015 Oct; 5():14775. PubMed ID: 26456301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lassa viral dynamics in non-human primates treated with favipiravir or ribavirin.
    Lingas G; Rosenke K; Safronetz D; Guedj J
    PLoS Comput Biol; 2021 Jan; 17(1):e1008535. PubMed ID: 33411731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Favipiravir Alone and in Combination With Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever.
    Oestereich L; Rieger T; Lüdtke A; Ruibal P; Wurr S; Pallasch E; Bockholt S; Krasemann S; Muñoz-Fontela C; Günther S
    J Infect Dis; 2016 Mar; 213(6):934-8. PubMed ID: 26531247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever.
    Raabe VN; Kann G; Ribner BS; Morales A; Varkey JB; Mehta AK; Lyon GM; Vanairsdale S; Faber K; Becker S; Eickmann M; Strecker T; Brown S; Patel K; De Leuw P; Schuettfort G; Stephan C; Rabenau H; Klena JD; Rollin PE; McElroy A; Ströher U; Nichol S; Kraft CS; Wolf T;
    Clin Infect Dis; 2017 Sep; 65(5):855-859. PubMed ID: 29017278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribavirin's antiviral mechanism of action: lethal mutagenesis?
    Crotty S; Cameron C; Andino R
    J Mol Med (Berl); 2002 Feb; 80(2):86-95. PubMed ID: 11907645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Favipiravir to Treat Lassa Virus Infection in Macaques.
    Rosenke K; Feldmann H; Westover JB; Hanley PW; Martellaro C; Feldmann F; Saturday G; Lovaglio J; Scott DP; Furuta Y; Komeno T; Gowen BB; Safronetz D
    Emerg Infect Dis; 2018 Sep; 24(9):1696-1699. PubMed ID: 29882740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of action of ribavirin in antiviral therapies.
    Tam RC; Lau JY; Hong Z
    Antivir Chem Chemother; 2001 Sep; 12(5):261-72. PubMed ID: 11900345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hexestrol, an estrogen receptor agonist, inhibits Lassa virus entry.
    Zhang Z; Takenaga T; Fehling SK; Igarashi M; Hirokawa T; Muramoto Y; Yamauchi K; Onishi C; Nakano M; Urata S; Groseth A; Strecker T; Noda T
    J Virol; 2024 Jul; 98(7):e0071424. PubMed ID: 38809021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring of Lassa virus infection in suspected and confirmed cases in Ondo State, Nigeria.
    Salu OB; Amoo OS; Shaibu JO; Abejegah C; Ayodeji O; Musa AZ; Idigbe I; Ezechi OC; Audu RA; Salako BL; Omilabu SA
    Pan Afr Med J; 2020; 36():253. PubMed ID: 33014249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel BSL-2 Lassa virus reverse genetics system modelling the complete viral life cycle.
    Hu X; Bai X; Tian F; Xing Y; Shi Y; Tong Y; Zhong J
    Emerg Microbes Infect; 2024 Dec; 13(1):2356149. PubMed ID: 38747061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depletion of GTP pool is not the predominant mechanism by which ribavirin exerts its antiviral effect on Lassa virus.
    Ölschläger S; Neyts J; Günther S
    Antiviral Res; 2011 Aug; 91(2):89-93. PubMed ID: 21616094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a macrocyclic compound targeting the lassa virus polymerase.
    Aida-Ficken V; Kelly JA; Chatterjee P; Jenks MH; McMullan LK; Albariño CG; Montgomery JM; Seley-Radtke KL; Spiropoulou CF; Flint M
    Antiviral Res; 2024 Aug; 228():105923. PubMed ID: 38844175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 25-Hydroxycholesterol Inhibition of Lassa Virus Infection through Aberrant GP1 Glycosylation.
    Shrivastava-Ranjan P; Bergeron É; Chakrabarti AK; Albariño CG; Flint M; Nichol ST; Spiropoulou CF
    mBio; 2016 Dec; 7(6):. PubMed ID: 27999160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ebola virus dynamics in mice treated with favipiravir.
    Madelain V; Oestereich L; Graw F; Nguyen TH; de Lamballerie X; Mentré F; Günther S; Guedj J
    Antiviral Res; 2015 Nov; 123():70-7. PubMed ID: 26343011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies.
    Cross RW; Mire CE; Branco LM; Geisbert JB; Rowland MM; Heinrich ML; Goba A; Momoh M; Grant DS; Fullah M; Khan SH; Robinson JE; Geisbert TW; Garry RF
    Antiviral Res; 2016 Sep; 133():218-222. PubMed ID: 27531367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lassa and Ebola virus inhibitors identified using minigenome and recombinant virus reporter systems.
    Welch SR; Guerrero LW; Chakrabarti AK; McMullan LK; Flint M; Bluemling GR; Painter GR; Nichol ST; Spiropoulou CF; Albariño CG
    Antiviral Res; 2016 Dec; 136():9-18. PubMed ID: 27771389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Lassa antiviral compound ST-193 in a guinea pig model.
    Cashman KA; Smith MA; Twenhafel NA; Larson RA; Jones KF; Allen RD; Dai D; Chinsangaram J; Bolken TC; Hruby DE; Amberg SM; Hensley LE; Guttieri MC
    Antiviral Res; 2011 Apr; 90(1):70-9. PubMed ID: 21371508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zika Virus Replication Is Substantially Inhibited by Novel Favipiravir and Interferon Alpha Combination Regimens.
    Pires de Mello CP; Tao X; Kim TH; Bulitta JB; Rodriquez JL; Pomeroy JJ; Brown AN
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ribavirin does not potentiate favipiravir antiviral activity against Ebola virus in non-human primates.
    Madelain V; Duthey A; Mentré F; Jacquot F; Solas C; Lacarelle B; Vallvé A; Barron S; Barrot L; Mundweiler S; Thomas D; Carbonnelle C; Raoul H; de Lamballerie X; Guedj J
    Antiviral Res; 2020 May; 177():104758. PubMed ID: 32135218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.